Shares of Canopy Growth Corp CGC, a Canada-based cannabis company, surged Wednesday morning after announcing an expansion of a partnership with minority shareholder Constellation Brands, Inc. STZ.
Constellation Brands said it will invest C$5 billion ($4 billion) in Canopy, which would increase its ownership stake to 38 percent. As part of the agreement, Constellation will acquire new shares directly from Canopy at a 37.9-percent premium to Canopy's five-day volume weighted average price on the Toronto Stock Exchange.
Canopy will use the proceeds from the transaction to strategically build and/or acquire key assets to establish a global scale.
The Sector Reacts
The transaction is the largest of its kind to date in the cannabis space and the nearly 40-percent premium paid by Constellation likely supported upside in other cannabis-related names Wednesday morning.
- Canopy Growth was up nearly 40 percent.
- Cronos Group Inc CRON, a company dedicated towards changing and removing negative misconceptions about cannabis, was trading higher by 12 percent.
- Tilray Inc TLRY, a company in engaged in research, cultivation, production and distribution of cannabis, was trading higher by 11 percent.
- ETFMG Alternative Harvest ETF MJ, an index that tracks the performance of companies engaged in legal activities of cannabis for medical or non-medical purposes, was trading higher by 6 percent.
- GW Pharmaceuticals GWPH, a developer of cannabinoid prescription medicines, was trading higher by 1.2 percent. GWPH shares got a boost from Stifel, which initiated coverage on the stock with a Buy rating.
Cannabis investors can't afford to miss the Benzinga Cannabis Capital Conference on August 17, a premier gathering of investors and entrepreneurs painting an honest picture of the opportunities and challenges in cannabis investing. Space is limited — get your tickets before they sell out.
Related Links:
The Cannabis Industry's Go-Public Frenzy: A Chat With Companies That IPOed This Year
AxisWire: Cannabis Companies Are Moving To Canada, Its Friendlier Legal Climate
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
